Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 23, 2014
Semi-physiological pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for thrombocytopenia in ratsShinji Kobuchi, Yukako Ito, Taro Hayakawa, et al.
Journal of Pharmacological and Toxicological Methods|July 30, 2014
Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in ratsShinji Kobuchi, Yukako Ito, Taro Hayakawa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 28, 2009
Effect of serum lipids on the pharmacokinetics of atazanavir in hyperlipidemic ratsKeizo Fukushima, Masakazu Shibata, Kazunori Mizuhara, et al.
Biopharmaceutics & Drug Disposition|July 10, 2013
A predictive biomarker for altered 5-fluorouracil pharmacokinetics following repeated administration in a rat model of colorectal cancerShinji Kobuchi, Shota Kuwano, Kazuki Imoto, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 22, 2014
Semi-physiological pharmacokinetic-pharmacodynamic modeling and simulation of 5-fluorouracil for the whole time course of alterations in leukocyte, neutrophil and lymphocyte counts in ratsShinji Kobuchi, Yukako Ito, Taro Hayakawa, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2016
Transport of Azithromycin into Extravascular Space in RatsShinji Kobuchi, Miki Aoki, Chiaki Inoue, et al.
Biological & Pharmaceutical Bulletin|November 5, 2014
Application of dissolving microneedles to glucose monitoring through dermal interstitial fluidYukako Ito, Mayu Taniguchi, Asuka Hayashi, et al.
International Journal of Medical Sciences|March 17, 2025
Data Mining of the FDA Adverse Event Reporting System and Animal Experiments for Assessment of Rhabdomyolysis Risk Associated with Lipid-lowering DrugsShinji Kobuchi, Daisuke Sugiyama, Anna Iima, et al.
Pageof 7